India IPO SEBI DRHP Activity Filings — May 11, 2026

Voluntary delisting from CSE per SEBI Reg 5/6 (2021) while retaining BSE listing, streamlines exchange presence without shareholder exit disruption

Appointed Ms. Deepa Garg (ICSI Associate, PG Rajasthan Tech Univ, NIL shares) as Additional Independent Director effective May 11, 2026, bolstering governance ahead of GM

Confirmed demat/listing of 20,135 physical shares (16 folios, Apr 16-30, 2026) on BSE (511218)/NSE (SHRIRAMFIN) per Reg 74(5), enhances liquidity and compliance

RTA (Integrated Registry) verified mutilated certificates substituted to NSDL/CDSL as owners, completes demat process signaling strong depository integration

BSE/NSE no-objection (May 11 letters, NSE ref 587/2026-27) for reclassifying Mr/Ms Shibulal from Promoter to Public under Reg 31A, increases free float perception post Apr30/May1 disclosures

Reclassification approval follows swift application (May1, 2026), demonstrates regulatory efficiency and reduced promoter control overhang

Board meeting May 19, 2026 for audited standalone/consolidated FY/Q4 Mar31 results and NSE listing approval (BSE scrip 531889), potential dual-listing catalyst

Trading window closed Apr1 to 48hrs post-May19 meeting, indicates disciplined insider compliance amid listing push

CCI hearing adjournment from May11 to May25 for arguments, no adverse outcome disclosed since Apr24 intimation, maintains status quo

3/5 companies (Aar Shyam, Shriram, Nurture) advancing listing/demat actions vs 2 regulatory holds, outperforms stagnant IPO pipeline

Quick reclass approval (11 days from application) vs typical delays, relative outperformance in exchange responsiveness

Demat volume 20,135 shares QoQ (Apr16-30 period) shows accelerating physical-to-demat conversion trend for legacy folios

Voluntary CSE delisting without exit opportunity to shareholders per SEBI (2021) Regs, potential minor liquidity reduction for CSE traders

New director appointment subject to ensuing GM approval, shareholder dissent risk if not ratified

Ongoing undisclosed CCI matter (since Apr24) adjourned to May25, persistent uncertainty in competition probe

No details on CCI matter nature/outcome in Reg30 intimation, opacity vs peers with fuller updates

Only 16 folios (20k shares) processed Apr16-30, slow physical conversion pace signals lingering legacy certificate risks

Shibulal reclass to Public reduces promoter group stake perception, but monitor for governance shifts post-change

Trading window closure to post-May19 implies delayed Q4/FY Mar31 disclosures, potential earnings surprise risk

0/5 new IPO filings, only compliance/listing tweaks vs expected uptick, subdued monitor stream momentum

5/5 neutral filings (no bullish), lacks conviction signals amid May regulatory cluster

Formerly Integrated Industries, rebranding opacity could confuse investors pre-NSE listing

Board to approve NSE listing May19 alongside FY results (BSE 531889), dual-listing alpha via liquidity/visibility boost

Fresh 20k share demat confirmation accelerates full dematerialization, opportunity for improved trading volumes

Promoter reclass approval elevates public shareholding, potential index inclusion/re-rating catalyst post May11 letters

CSE delisting retains BSE listing, opportunity to consolidate liquidity on premium exchange

Hearing reschedule to May25 offers closure window, buy uncertainty dip if no escalation

Audited Q4/FY Mar31 results May19, scout for growth outliers vs BSE peers in industrials

11-day no-objection turnaround vs sector norms, signals strong compliance edge for future filings

NSDL/CDSL substitution as owners post-RTA verification, opportunity in fintech depository tailwinds

New independent director (NIL holdings) adds board diversity, M&A/strategic pivot potential pre-GM

60% filings (3/5) on listings/demat, arbitrage opportunity in under-listed smallcaps eyeing NSE/BSE expansion

2/5 filings (Shriram, Aar Shyam) confirm demat/delisting processes (e.g., 20k shares demat), implies 40% of activity focused on exchange streamlining vs new IPOs; bullish for liquidity but capex-light

Maruti adjournment + Infosys/Aar Shyam approvals (May11) show balanced exchange/CCI responsiveness; aggregate 3 approvals vs 1 delay, supports efficient India listing ecosystem

Nurture Well eyes NSE post-BSE (May19), echoes Aar Shyam BSE retention; 2/5 (40%) theme on multi-exchange strategy, potential volume multiplier for smallcaps

100% neutral across 5 filings (materiality avg 5.4/10), no margin/YoY trends disclosed; reflects administrative phase in IPO cycle, low volatility setup

3 events (May19 board, May25 CCI, ensuing GM) from filings, concentrated catalyst calendar vs dispersed prior periods; heightens short-term monitoring for listing alpha

Infosys reclass + Shriram legacy demat + Aar Shyam governance tweak; pattern in 60% filings reducing legacy overhangs, aids modern IPO-readiness

Monitor audited Q4/FY Mar31 2026 results + NSE listing decision for liquidity catalyst, May 19, 2026

Track arguments/outcome on undisclosed matter for regulatory resolution, rescheduled May 25, 2026

Watch shareholder approval for Ms. Deepa Garg directorship + delisting public notice, ensuing post-May11 GM

Follow-up on remaining physical certificates post-20k share batch (Apr16-30), next RTA confirmation expected Q2 2026

Monitor post-approval implementation + free float impact on indices/promoter holdings, available on www.infosys.com post-May11

Insider dealing resumption 48hrs post-May19 board, watch for activity signaling conviction on results/listing

Public newspaper publication per SEBI Regs for CSE exit, timeline post-May11 board (12-1:50PM)

New filings post-May11 for IPO approvals, given 0/5 this period vs historical avg